WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Alexandra Keck
Associate
Antitrust and Competition
Washington, D.C.
akeck@wsgr.com

D202-791-8006

Download vCard
Open PDF

Alexandra Keck is an associate in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where she is a member of the firm’s antitrust practice. Her work focuses on a broad array of antitrust issues, including government investigations, antitrust litigation, competition concerns in mergers and acquisitions, and business counseling. Alexandra has represented leading companies in numerous industries, including pharmaceuticals, digital advertising, semiconductors, telecommunications, hospitals, medical devices, and technology and software.

While attending law school, Alexandra interned for the Bureau of Competition at the Federal Trade Commission and externed for the Honorable Randolph Moss of the U.S. District Court for the District of Columbia. She also served as student counsel for the Appellate Courts Immersion Clinic at Georgetown University Law Center, where she worked on public-interest federal appellate litigation, and assisted as a law fellow in the Legal Research and Writing Program.

Alexandra is practicing virtually in Michigan, where she is licensed.

Experience

Alexandra Keck is an associate in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where she is a member of the firm’s antitrust practice. Her work focuses on a broad array of antitrust issues, including government investigations, antitrust litigation, competition concerns in mergers and acquisitions, and business counseling. Alexandra has represented leading companies in numerous industries, including pharmaceuticals, digital advertising, semiconductors, telecommunications, hospitals, medical devices, and technology and software.

While attending law school, Alexandra interned for the Bureau of Competition at the Federal Trade Commission and externed for the Honorable Randolph Moss of the U.S. District Court for the District of Columbia. She also served as student counsel for the Appellate Courts Immersion Clinic at Georgetown University Law Center, where she worked on public-interest federal appellate litigation, and assisted as a law fellow in the Legal Research and Writing Program.

Alexandra is practicing virtually in Michigan, where she is licensed.

Education
  • J.D., Georgetown University Law Center, 2019Cum Laude; Articles Editor, Georgetown Law Journal
  • B.A., Economics and English, University of Notre Dame, 2015
Admissions
  • Bar of the District of Columbia
  • State Bar of Michigan
  • U.S. Court of Appeals for the Eleventh Circuit
Credentials
Education
  • J.D., Georgetown University Law Center, 2019Cum Laude; Articles Editor, Georgetown Law Journal
  • B.A., Economics and English, University of Notre Dame, 2015
Admissions
  • Bar of the District of Columbia
  • State Bar of Michigan
  • U.S. Court of Appeals for the Eleventh Circuit

Select Publications

  • Co-author,"Jury Finds Gilead and Teva Did Not Engage in an Anticompetitive Pay-for-Delay Scheme for HIV Drugs," Wilson Sonsini Alert, July 5, 2023

  • Co-author, "Treating Like Cases Alike: The Need for Consistency in the Forthcoming Merger Guidelines," CPI Antitrust Chronicle, 2022

  • Co-author with S. Sher, "Merger Guidelines Reform: If It Ain't Broke....," Antitrust Report, LexisNexis, July 2022

  • Co-author with J. Ferris and S. Sher, “Merger Control Laws and Regulations 2022,” U.S. chapter in Global Legal Insight - Merger Control 2022, June 2022
  • Co-author with K. Sharp and J. VanHooreweghe, “First DOJ Criminal Wage-Fixing and No-Poach Trials End in Acquittals,” Wilson Sonsini Alert, April 18, 2022
  • Co-author with J. Sessions, J. Ceccio, and A. Poonai, “United States: IP and Antitrust” chapter, Global Competition Review’s Americas Antitrust Review 2022, October 2021

  • Co-author with J. Sessions, J. Ceccio, and A. Poonai, "Federal Trade Commission Limits Broadcom’s Exclusivity Agreements, Volume Discounting," Wilson Sonsini Alert, July 8, 2021
  • Co-author with S. Sher, A. Simmerman, and E. Marco, "The Anthem-Cigna Merger Litigation Saga: Key Insights for Future Deals," Wilson Sonsini Alert, May 5, 2021
  • Co-author with B. Coffman and S. Sher, Risk Allocation in Merger Agreements in an Era of Increased Enforcement, Wilson Sonsini Goodrich & Rosati Report, October 23, 2020
  • Co-author, "The Impact of COVID-19 on Merger Reviews: Practical Considerations for Global Deals," Wilson Sonsini Alert, March 20, 2020
  • Co-author, "The Impact of COVID-19 on Merger Reviews: Practical Considerations for the United States," Wilson Sonsini Alert, March 20, 2020
Insights

Select Publications

  • Co-author,"Jury Finds Gilead and Teva Did Not Engage in an Anticompetitive Pay-for-Delay Scheme for HIV Drugs," Wilson Sonsini Alert, July 5, 2023

  • Co-author, "Treating Like Cases Alike: The Need for Consistency in the Forthcoming Merger Guidelines," CPI Antitrust Chronicle, 2022

  • Co-author with S. Sher, "Merger Guidelines Reform: If It Ain't Broke....," Antitrust Report, LexisNexis, July 2022

  • Co-author with J. Ferris and S. Sher, “Merger Control Laws and Regulations 2022,” U.S. chapter in Global Legal Insight - Merger Control 2022, June 2022
  • Co-author with K. Sharp and J. VanHooreweghe, “First DOJ Criminal Wage-Fixing and No-Poach Trials End in Acquittals,” Wilson Sonsini Alert, April 18, 2022
  • Co-author with J. Sessions, J. Ceccio, and A. Poonai, “United States: IP and Antitrust” chapter, Global Competition Review’s Americas Antitrust Review 2022, October 2021

  • Co-author with J. Sessions, J. Ceccio, and A. Poonai, "Federal Trade Commission Limits Broadcom’s Exclusivity Agreements, Volume Discounting," Wilson Sonsini Alert, July 8, 2021
  • Co-author with S. Sher, A. Simmerman, and E. Marco, "The Anthem-Cigna Merger Litigation Saga: Key Insights for Future Deals," Wilson Sonsini Alert, May 5, 2021
  • Co-author with B. Coffman and S. Sher, Risk Allocation in Merger Agreements in an Era of Increased Enforcement, Wilson Sonsini Goodrich & Rosati Report, October 23, 2020
  • Co-author, "The Impact of COVID-19 on Merger Reviews: Practical Considerations for Global Deals," Wilson Sonsini Alert, March 20, 2020
  • Co-author, "The Impact of COVID-19 on Merger Reviews: Practical Considerations for the United States," Wilson Sonsini Alert, March 20, 2020
Focus Areas
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • Antitrust and Competition
  • Antitrust and Intellectual Property
  • Third-Party Merger and Non-Merger Antitrust Representation
Recent Insights
Client Highlights
Court Denies Plaintiffs Leave to Amend in Replacement Tires Antitrust MDL, Dismissing Alleged Price-Fixing Cases with Prejudice
A Wilson Sonsini team recently obtained a full dismissal with prejudice on behalf of Continental Aktiengesellschaft and Continental Tire the Americas, LLC of alleged price-fixing claims on replacement tires. 
Learn More
Alerts
Jury Finds Gilead and Teva Did Not Engage in an Anticompetitive Pay-for-Delay Scheme for HIV Drugs
On June 30, 2023, a jury in the Northern District of California found Gilead and Teva not liable in a trial accusing the companies of engaging in an illegal reverse payment to delay generic versions of two HIV drugs, Truvada (emtricitabine/tenofovir) and Atripla (efavirenz-/-emtricitabine-/-tenofovir). Following a five-week trial and two days of deliberations, the jury found that the plaintiffs failed to show that: 1) Gilead had market power within a market that included Truvada and/or Atripla, and 2) Gilead made a reverse payment to Teva to delay the entry of generic competition.1 This case marks the third jury verdict in favor of defendants in reverse-payment cases since the 2013 FTC v. Actavis decision—there have been no verdicts for plaintiffs.2
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.